492: Neonatal outcomes in gestational diabetes managed with insulin vs. glyburide therapy: a cost-effectiveness analysis

To compare neonatal outcomes and assess the cost-effectiveness of insulin therapy versus glyburide therapy in women with gestational diabetes in the context of most recent randomized controlled trials.

Source: American Journal of Obstetrics and Gynecology - December 25, 2018 Category: OBGYN Authors: Allison J. Munn, Alyssa R. Hersh, Abigail R. Vinson, Thomas D. Brennan, Amy M. Valent, Aaron B. Caughey Tags: Poster Session III Source Type: research